Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

3.85
Delayed Data
As of 4:00pm ET
 -0.22 / -5.41%
Today’s Change
3.08
Today|||52-Week Range
12.12
+23.40%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close4.07
Today’s open4.11
Day’s range3.83 - 4.14
Volume50,676
Average volume (3 months)87,699
Market cap$75.9M
Data as of 4:00pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+85.82%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales7.00
Price/Book0.56

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...-0.30-3.97%
CTSOCytosorbents Corp0.000.00%
CDXCChromadex Corp-0.33-5.34%
NATRNatures Sunshine Pro...+0.10+0.84%
Data as of 4:00pm ET, 01/16/2018

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$13.6M
Annual profit (last year)-$52.9M
Net profit margin-389.49%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer &
Executive VP
Jeffrey Hackman
Chief Financial Officer &
Senior Vice President
Michael Dennis Price
Corporate headquarters
Vancouver, British Columbia

Forecasts